Atypical Antipsychotics: Where is the Science, Where is the Evidence?
The Carlat Psychiatry Report, Volume 11, Number 1, January 2013
P Ken Gillman, MBBS
Director, Psychotropical (www.psychotropical.com), Bucasia, Queensland, Australia
Dr. Gillman has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
Any psychiatrist who has practiced during the last decade has probably written more than a few prescriptions for an atypical antipsychotic. But do these drugs provide any clear advantages over their predecessors?